Lowbica HCT Tablet 10/40/12.5 Milligrams

Adult dose

This medication should be taken once daily with water, regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). The recommended dosing is as follows: - 5/20/12.5mg: Administered to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/20mg combination therapy. - 5/40/12.5mg: Administered to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/40mg.

Child dose

The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age, so its use is not recommended.

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Do not take this medication if you have a history of allergies or hypersensitivity reactions to this medication or any of its components, are pregnant or breastfeeding, have severe hypotension or heart valve disease, have acute heart failure or severe kidney and liver dysfunction. Caution is required for those with low blood volume or electrolyte imbalances as blood pressure may drop rapidly at the onset of treatment, and their condition should be closely monitored during treatment. Patients with impaired kidney function or kidney transplant recipients, those with renovascular hypertension, and those with severe liver dysfunction require special precautions when taking this medication. Since this medication lowers blood pressure, it can cause dizziness; therefore, caution should be exercised when driving or operating machinery. This medication may interact with other drugs, so you must consult with your doctor or pharmacist, especially if you are taking lithium, non-steroidal anti-inflammatory drugs, or other antihypertensive medications. This medication can cause electrolyte imbalances, so it is important to regularly check serum electrolyte levels through blood tests. If breastfeeding, it is recommended to discontinue nursing or stop taking the medication as its components may pass into breast milk. The safety and efficacy of this medication have not been established in children under 18 years of age, so its use is not recommended. Elderly patients are advised to start at a low dose considering the possibility of impaired kidney and liver functions. In the case of overdose, symptoms such as hypotension, palpitations, and dizziness may occur, necessitating immediate medical attention. This medication should be stored in a tightly closed container to protect it from light and moisture, and should be kept out of reach of children; transferring it to another container is to be avoided.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, difficulty breathing or shortness of breath, asthma attack, cough with fever and abnormal breathing, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizure, altered consciousness, visual disturbances, paralysis, urination changes

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

Round film-coated tablets in reddish color

Package unit

28 tablets (14 tablets/PTP X 2)/box